• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥地利结直肠癌患者按性别、年龄和分期的生存率。

Survival of patients with colorectal cancer in Austria by sex, age, and stage.

作者信息

Haidinger Gerald, Waldhoer Thomas, Hackl Monika, Vutuc Christian

机构信息

Department of Epidemiology, Centre of Public Health, Medical University of Vienna, Vienna, Austria.

出版信息

Wien Med Wochenschr. 2006 Oct;156(19-20):549-51. doi: 10.1007/s10354-006-0339-9.

DOI:10.1007/s10354-006-0339-9
PMID:17103293
Abstract

This paper for the first time presents Austrian data on survival of patients, diagnosed from 1998 through 2002, with colon cancer and with rectal cancer. Cumulative relative survival rates were calculated by age, standardized for all ages and stages combined, and by age groups (< 50 years, 50-64 years, and =65 years) according to stages (localized, regional metastases and distant metastases). In carcinoma of the colon 5-year relative survival was 66 % in males and 64 % in females. In carcinoma of the rectum 5-year relative survival was 64 % in males and 67 % in females. Compared to the earlier results from the Tyrol (based on patients diagnosed from 1990 through 1994) the 5-year survival of patients with colon cancer increased from 55 % to 66 % in males and from 58 % to 64 % in females. In patients with rectal cancer 5-year survival increased from 44 % to 64 % in males and from 46 % to 67 % in females. This increase in part can be explained by a positive effect of early detection and of better treatment.

摘要

本文首次呈现了1998年至2002年期间奥地利结肠癌和直肠癌患者的生存数据。按年龄计算累积相对生存率,并对所有年龄和阶段进行标准化,同时根据阶段(局部、区域转移和远处转移)按年龄组(<50岁、50 - 64岁和≥65岁)计算。结肠癌患者中,男性5年相对生存率为66%,女性为64%。直肠癌患者中,男性5年相对生存率为64%,女性为67%。与蒂罗尔州早期结果(基于1990年至1994年诊断的患者)相比,结肠癌患者的5年生存率男性从55%提高到66%,女性从58%提高到64%。直肠癌患者的5年生存率男性从44%提高到64%,女性从46%提高到67%。这种提高部分可归因于早期检测和更好治疗的积极作用。

相似文献

1
Survival of patients with colorectal cancer in Austria by sex, age, and stage.奥地利结直肠癌患者按性别、年龄和分期的生存率。
Wien Med Wochenschr. 2006 Oct;156(19-20):549-51. doi: 10.1007/s10354-006-0339-9.
2
Population-based survival analysis of colorectal cancer patients in Singapore, 1968-1992.1968 - 1992年新加坡结直肠癌患者基于人群的生存分析。
Int J Cancer. 2002 May 20;99(3):460-5. doi: 10.1002/ijc.10333.
3
Aspects of survival from colorectal cancer in Denmark.丹麦结直肠癌的生存情况
Dan Med J. 2012 Apr;59(4):B4428.
4
Why did treatment rates for colorectal cancer in south east England fall between 1982 and 1988? The effect of case ascertainment and registration bias.1982年至1988年间,英格兰东南部的结直肠癌治疗率为何下降?病例确诊及登记偏倚的影响。
J Public Health Med. 1995 Dec;17(4):419-28.
5
Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany.基于人群的未筛选结直肠癌患者登记:德国波恩/莱茵-西格地区的五年生存率
Z Gastroenterol. 2005 Feb;43(2):149-54. doi: 10.1055/s-2004-813631.
6
Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan.20年间结直肠癌的变化:来自日本大肠癌多机构登记处的扩展报告
Dis Colon Rectum. 2003 Oct;46(10 Suppl):S32-43. doi: 10.1097/01.DCR.0000083389.92214.AA.
7
The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.结直肠癌筛查计划对右侧结直肠癌检测的影响。在曼托瓦地区进行的一项为期5年的队列研究。
Int J Colorectal Dis. 2015 Dec;30(12):1627-37. doi: 10.1007/s00384-015-2352-1. Epub 2015 Aug 9.
8
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
9
Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010.晚期结直肠癌和直肠癌死亡率的上升表明有必要进行筛查:1994 - 2010年爱尔兰的一项基于人群的研究
BMC Gastroenterol. 2014 May 13;14:92. doi: 10.1186/1471-230X-14-92.
10
Site-specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients: a competing risks survival analysis.伊朗结直肠癌患者生存预后因素的部位特异性评估:一项竞争风险生存分析
Asian Pac J Cancer Prev. 2009;10(5):815-21.

引用本文的文献

1
Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer.进展期肿瘤手术与转移性结直肠癌的根治性切除率提高及生存率改善相关。
Cancers (Basel). 2019 Feb 14;11(2):218. doi: 10.3390/cancers11020218.
2
Evaluation of prognostic factors effect on survival time in patients with colorectal cancer, based on Weibull Competing-Risks Model.基于威布尔竞争风险模型评估预后因素对结直肠癌患者生存时间的影响。
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(1):54-59.
3
Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease.

本文引用的文献

1
Improvement in colorectal cancer survival: a population-based study.结直肠癌生存率的提高:一项基于人群的研究。
Eur J Cancer. 2005 Oct;41(15):2297-303. doi: 10.1016/j.ejca.2005.01.028. Epub 2005 Sep 1.
2
Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands.荷兰北荷兰省/弗莱福兰省上皮癌的阶段特异性生存率
Eur J Cancer. 2005 Oct;41(15):2321-30. doi: 10.1016/j.ejca.2005.03.037. Epub 2005 Aug 26.
3
Cancer mortality in Austria: 1970-2002.奥地利的癌症死亡率:1970 - 2002年。
病例报告:一名错配修复缺陷的转移性结直肠癌伴大块肿瘤患者对帕博利珠单抗有显著反应。
ESMO Open. 2016 Dec 15;1(6):e000084. doi: 10.1136/esmoopen-2016-000084. eCollection 2016.
4
Does the prognosis of colorectal cancer vary with tumor site?结直肠癌的预后是否因肿瘤部位而异?
Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):199-209.
Wien Klin Wochenschr. 2004 Oct 30;116(19-20):669-75. doi: 10.1007/s00508-004-0248-0.
4
[Recommendations on the diagnosis and multimodal primary therapy of rectal carcinomas 2004].《2004年直肠癌诊断与多模式初始治疗建议》
Wien Klin Wochenschr. 2005 Feb;117(4):154-71. doi: 10.1007/s00508-005-0323-1.
5
Regression models for relative survival.相对生存的回归模型。
Stat Med. 2004 Jan 15;23(1):51-64. doi: 10.1002/sim.1597.
6
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.欧洲癌症研究与治疗组织癌症生存率研究项目-3:1990 - 1994年确诊癌症患者的生存情况——结果与评论
Ann Oncol. 2003;14 Suppl 5:v61-118. doi: 10.1093/annonc/mdg754.
7
[Drug therapy of colorectal carcinoma].[结直肠癌的药物治疗]
Wien Klin Wochenschr. 2002 Jun 14;114(10-11):368-76.
8
[Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Wien Klin Wochenschr. 1991;103(10):288-95.